Laboratory Compliance | Tissuepathology.com

Proscia Achieves SOC 2 Type II Certification, Strengthening Enterprise Trust

Erica Goodpaster — Thu, 04 Dec 2025 13:51:20 +0000

Compliance with independent security standards comes as Proscia accelerates digital pathology deployments at scale PHILADELPHIA – December 3, 2025 – Proscia®, a pathology AI company, has successfully completed its SOC 2 Type II audit. This milestone underscores the company’s enterprise-grade security and operational rigor, reinforcing its role as the partner of choice for large-scale digital pathology […]

The post Proscia Achieves SOC 2 Type II Certification, Strengthening Enterprise Trust first appeared on Tissuepathology.com.

Indica Labs: Pharma Services Launches GCP-Compliant Image Analysis Service

Erica Goodpaster — Wed, 09 Jul 2025 11:48:58 +0000

Albuquerque, NM, July 8, 2025 – Indica Labs, the global leader in AI-powered digital pathology software and services, today announces that their Pharma Services team is offering quantitative image analysis studies designed and performed to Good Clinical Practice (GCP) standards. With GCP image analysis services, customers can rest assured that the quantitative image analysis data in their translational and […]

The post Indica Labs: Pharma Services Launches GCP-Compliant Image Analysis Service first appeared on Tissuepathology.com.

Lumea: Top 5 Reasons to Adopt Digital Pathology Today (Spoiler: AI Isn’t One of Them)

Erica Goodpaster — Fri, 14 Feb 2025 12:53:00 +0000

From the Lumea blog: Digital transformation is reshaping industries across the globe, and pathology is no exception. While much of the “dig path” buzz centers around the potential of artificial intelligence (AI) as a diagnostic aid, there are immediate, tangible benefits to adopting digital pathology that don’t rely on AI at all. Here are five […]

The post Lumea: Top 5 Reasons to Adopt Digital Pathology Today (Spoiler: AI Isn’t One of Them) first appeared on Tissuepathology.com.

Pre-registration for Visiopharm USCAP 2022 Seminar

Erica Goodpaster — Tue, 15 Mar 2022 12:31:00 +0000

Visiopharm has announced preregistration for their USCAP 2022 seminar. AI-driven stain quality standardization of IHC Featuring Marilyn M. Bui, MD, Ph.D., Moffitt Cancer Center and Martin Kristensson, Visiopharm Wednesday, March 23rd, 2022 12:00 – 1:00 PM PST Exhibitor seminar room 3 (West exhibit hall A). If you can’t join in person, you should still sign […]

The post Pre-registration for Visiopharm USCAP 2022 Seminar first appeared on Tissuepathology.com.

Webcast | COVID-19 and the Rise of Digital Pathology

Dr. Keith J. Kaplan — Mon, 19 Oct 2020 13:00:03 +0000

. USCAP Interactive Webcast, October 21, 2020 11:00 PDT. Learn more and Register A week after the declaration of a national emergency, the Centers for Medicare and Medicaid Services (CMS) temporarily lifted the CLIA license requirement for the sign-out of pathology cases at remote locations. The FDA also exercised regulatory enforcement discretion regarding how digital […]

The post Webcast | COVID-19 and the Rise of Digital Pathology first appeared on Tissuepathology.com.

Roche Receives FDA Approval for First HIV-1/HIV-2 Qualitative Test on the Cobas 6800/8800 Systems in the Fight Against HIV/AIDS

Dr. Keith J. Kaplan — Tue, 01 Sep 2020 16:17:35 +0000

MEDIA RELEASE Detects, confirms and differentiates HIV-1 and HIV-2 infections providing clinicians with critical diagnostic data for personalised management of patients with HIV — from appropriate counseling on disease differences to targeted therapy Supports rapid molecular detection of acute HIV infection, which is critical in curbing further disease transmission Combines confirmatory HIV testing and HIV-1/HIV-2 […]

The post Roche Receives FDA Approval for First HIV-1/HIV-2 Qualitative Test on the Cobas 6800/8800 Systems in the Fight Against HIV/AIDS first appeared on Tissuepathology.com.